• Zosano Pharma (NASDAQ:ZSAN) Upgraded to “Buy” at Zacks Investment Research

    Zosano Pharma (NASDAQ:ZSAN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to …

    Read More
  • 0 0